Amgen Inc. (AMGN) News Headlines

▮ More

Date

Headline

11/1/2019 3:04:50 AM BGNE Soars, DRNA Hits New High On Roche Deal, FDA Heeds REPH's Request

10/31/2019 4:14:41 PM Amgen To Acquire 20.5% Stake In BeiGene For Approx. $2.7 Bln - Quick Facts

10/31/2019 4:01:20 PM Amgen Enters Strategic Collaboration With BeiGene

10/29/2019 4:30:29 PM Amgen Updates Guidance - Quick Facts

10/29/2019 4:07:44 PM Amgen Inc. (AMGN) Has Raised Its 2019 EPS Estimate To 14.20 - 14.45 From 13.75 - 14.30

10/29/2019 4:07:06 PM Amgen Inc. (AMGN) Has Raised Its 2019 Revenue Estimate To $22. 8- $23.0 Bln From $22.4-$22.9 Bln

10/29/2019 4:04:44 PM Amgen Inc. Q3 adjusted earnings Beat Estimates

10/29/2019 4:04:08 PM Amgen Reports Q3 EPS Of $3.27 Vs, $2.86 Last Year

10/29/2019 6:07:44 AM Amgen Q3 19 Earnings Conference Call At 5:00 PM ET

10/24/2019 9:19:17 AM Amgen Decides To Discontinue Original List Price Option For Repatha

10/24/2019 9:02:59 AM Amgen To Make Repatha Available At Its Lower List Price Option In 2020; 60% Lower List Price Of $5,850 Per Year

10/23/2019 4:03:46 PM Amgen Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Corp

10/23/2019 12:21:43 AM Amgen Appoints Peter Griffith As CFO, Succeeding David Meline, Effective Jan. 1

10/22/2019 7:34:39 PM Amgen CFO David Meline To Retire

10/22/2019 4:12:49 PM Amgen Inc. (AMGN) Declares $ 1.45 Dividend for Q4 19, Record Date 11/15/2019

10/22/2019 4:01:52 PM Amgen Declares Q4 Dividend Of $1.45/share, Payable Dec. 6/ Record Nov. 15

10/18/2019 9:16:37 AM Amgen: FDA Approves Earlier Use Of Nplate To Treat Immune Thrombocytopenia

10/18/2019 9:07:57 AM Amgen Says FDA Approves SBLA For Nplate For Earlier Use In Adults With Immune Thrombocytopenia

10/18/2019 1:18:18 AM Amgen : EVENITY Gets Positive CHMP Opinion For Treatment Of Severe Osteoporosis

10/18/2019 1:08:22 AM CHMP Adopts Positive Opinion For EVENITY To Treat Severe Osteoporosis In Postmenopausal Women At HighRisk Of Fracture